243 results match your criteria: "Japanese Red Cross Okayama Hospital[Affiliation]"

Blunt abdominal trauma causing intraperitoneal injury and/or bleeding can be life-threatening, requiring immediate intervention. Diagnosing these cases can be challenging, especially when pre-existing conditions are involved. Low-grade appendiceal mucinous neoplasm (LAMN) is a rare tumor of the appendix that can lead to pseudomyxoma peritonei.

View Article and Find Full Text PDF

Introduction: Osimertinib is the first-line treatment for patients with non-small cell lung cancer (NSCLC) who have EGFR mutations and favorable performance status (PS). Despite increasing clinical data on osimertinib, evidence in patients with an impaired PS remains limited. Therefore, a multicenter phase II trial (OPEN/TORG2040) was conducted to evaluate the efficacy and safety of first-line osimertinib for patients with EGFR mutation-positive NSCLC and poor PS.

View Article and Find Full Text PDF

Objective: To examine whether antimicrobial prophylaxis based on screening rectal cultures using selective media prevented acute bacterial prostatitis following transrectal prostate biopsy (TRPB).

Methods: In this multicenter, randomized controlled trial, we enrolled 403 patients undergoing TRPB with low risks of infectious complications. Patients were randomized into a cultured group (CG) or no cultured group (NCG).

View Article and Find Full Text PDF

Purpose: Medial meniscus (MM) posterior root tears (PRT) cause pathological medial extrusion (MMME) and posterior extrusion (MMPE), particularly during knee flexion, leading to rapidly progressive knee osteoarthritis. We investigated pre- and postoperative MM extrusion using three-dimensional open magnetic resonance imaging (MRI) following two pullout repair techniques: two simple stitches (TSS) and TSS with an additional all-inside suture to the posteromedial capsule (TSS-PM). We hypothesized that TSS-PM would decrease MM extrusion more effectively than TSS.

View Article and Find Full Text PDF

Limited data are available on the frequency and significance of body weight loss during cancer therapy. This study investigated the frequency of patients who experienced body weight loss during immune checkpoint inhibitor (ICI) plus chemotherapy for advanced non-small cell lung cancer (NSCLC) and the impact of weight loss on treatment outcomes. Using the clinical data of 370 patients with NSCLC who received a combination of ICI and chemotherapy at 13 institutions, this study investigated the frequency of body weight loss > 5% during treatment and determined the impact of body weight loss on patient outcomes.

View Article and Find Full Text PDF

Purpose: The effect of quadriceps muscle strength on medial joint space (MJS) narrowing after repair for medial meniscus (MM) posterior root tears (MMPRTs) has not yet been determined. This study aimed to evaluate the effect of preoperative and postoperative quadriceps muscle strength on the change in MJS (ΔMJS) in MMPRTs.

Methods: Thirty patients who underwent pullout repair for MMPRTs were retrospectively evaluated.

View Article and Find Full Text PDF

Purpose: In this study, we aimed to evaluate the changes in and the relationship between lower limb muscle strength and physical function before and after medial meniscus posterior root (MMPR) repair.

Methods: Thirty-three patients who underwent MMPR repair were evaluated. Pain was evaluated with the numerical rating scale (NRS), and knee flexor/extensor muscle strength was assessed using a handheld dynamometer.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of durvalumab, an immunotherapy drug, after chemoradiotherapy in patients with unresectable locally advanced non-small-cell lung cancer (LA-NSCLC), particularly those with poorer performance status or older age.
  • In a phase II trial with 86 participants, 61 received durvalumab after low-dose carboplatin and radiotherapy, showing a 12-month progression-free survival (PFS) rate of 51%, exceeding the expected 35%.
  • The treatment was deemed effective, with a median overall survival of 28.1 months, but pneumonitis was noted as the most common severe side effect.*
View Article and Find Full Text PDF
Article Synopsis
  • A study looked at the safety of continuing blood thinners (warfarin and DOACs) in patients needing a stomach procedure for early cancer.
  • It found that people taking warfarin didn't have any bleeding after the procedure, while some people taking DOACs did.
  • The researchers suggest that it's safer to keep using warfarin and that stopping DOACs too close to the procedure can lead to more bleeding problems.
View Article and Find Full Text PDF
Article Synopsis
  • Cancer cachexia frequently occurs in advanced non-small cell lung cancer (NSCLC) and its impact on chemotherapy is not fully understood.
  • A study involving 887 NSCLC patients identified that 31.7% experienced weight loss indicative of cachexia, with variations in quality of life (QOL) observed across different treatment groups.
  • Results showed that quality of life declined more significantly in chemotherapy patients compared to those receiving targeted therapies or immune checkpoint inhibitors, especially within the first week of treatment.
View Article and Find Full Text PDF

Background: Grey-white matter ratio (GWR) measured by head computed tomography (CT) scan is known as a neurological prognostication tool for out-of-hospital cardiac arrest (OHCA) survivors. The prognostic value of GWR obtained early (within two hours after return of spontaneous circulation [ROSC]) remains a matter of debate.

Methods: We conducted a multicenter, retrospective, observational study at five hospitals.

View Article and Find Full Text PDF

Background And Aims: The impact of hepatitis C virus (HCV) eradication via direct-acting antiviral (DAA) therapy on overall mortality, particularly non-liver-related mortality, is understudied.

Methods: We recruited 4180 patients with chronic HCV infection who achieved sustained virological response (SVR) (HCV eradication) through DAA therapy (n = 2501, SVR group) or who did not receive antiviral therapy (n = 1679, non-SVR group); 1236 from each group were chosen using propensity score matching. Causes of death and all-cause mortality, including non-liver-related diseases, were investigated.

View Article and Find Full Text PDF
Article Synopsis
  • - This study explores the effectiveness of combining immune checkpoint inhibitors durvalumab and tremelimumab (DT) for patients with hepatocellular carcinoma (HCC) who previously received treatments like atezolizumab plus bevacizumab (AB).
  • - Results showed objective response rates (ORRs) were highest in first-line treatment (44%), followed by second-line without prior AB (54%), and significantly lower in patients who had prior AB (5%), indicating that prior treatment heavily affects success.
  • - The findings suggest that while DT may be less effective after AB treatment, it can still yield similar results to first-line therapy in patients without prior AB, highlighting the importance of treatment history when planning HCC therapy.
View Article and Find Full Text PDF

Background/aim: Maintaining liver function throughout the treatment of hepatocellular carcinoma (HCC) is crucial, yet the impact of durvalumab plus tremelimumab (DT) treatment on liver function is not well understood. This multicenter study aimed to examine the changes in liver function during DT treatment.

Patients And Methods: This nationwide multicenter study included 80 patients who received DT treatment for unresectable HCC.

View Article and Find Full Text PDF

A 71-year-old man was admitted because of acute exacerbation of interstitial pneumonia following a right upper lobectomy for lung cancer. His respiratory failure worsened after admission, and he required mechanical ventilation. He was undergoing intensive immunosuppressive treatment, including high-dose corticosteroids and cyclosporine, and had watery diarrhea six times a day.

View Article and Find Full Text PDF

Indoxyl sulfate, a uremic toxin, is associated with mortality and cardiovascular events in patients with chronic kidney disease (CKD). This study aimed to evaluate the prognostic implications of serum indoxyl sulfate levels in patients with heart failure and CKD. This was a prospective multicenter observational study.

View Article and Find Full Text PDF

Introduction: The distal tibial nail (DTN) is a novel retrograde intramedullary nail used for distal tibial fracture stabilization. We investigated the clinical results of DTN use for distal tibial fractures and compared them with those reported in the literature on locking plates and antegrade intramedullary nails.

Materials And Methods: This multicenter, prospective, observational cohort study examined distal tibial fractures with AO/OTA classification 43 types: A1, A2, A3 or C1.

View Article and Find Full Text PDF

Introduction: ACE cleaves angiotensin I (Ang I) to angiotensin II (Ang II) inducing vasoconstriction via Ang II type 1 (AT1) receptor, while ACE2 cleaves Ang II to Ang (1-7) causing vasodilatation by acting on the Mas receptor. In diabetic kidney disease (DKD), it is still unclear whether plasma or urine ACE2 levels predict renal outcomes or not.

Research Design And Methods: Among 777 participants with diabetes enrolled in the Urinary biomarker for Continuous And Rapid progression of diabetic nEphropathy study, the 296 patients followed up for 9 years were investigated.

View Article and Find Full Text PDF

Purpose: This study aimed to evaluate the association between the progression of medial joint space (MJS) narrowing, medial meniscus extrusion (MME) and clinical scores and the tibial tunnel position in pullout repairs for medial meniscus posterior root tears (MMPRTs).

Methods: This retrospective study examined 54 patients. Changes in MJS (ΔMJS), MME (ΔMME) and clinical scores and their relationship with the tibial tunnel position were evaluated using correlation coefficients.

View Article and Find Full Text PDF

Purpose: The second-look arthroscopic score of pullout repair for medial meniscus posterior root tears (MMPRTs) is associated with contemporaneous clinical scores and progression of cartilage damage. However, the relationship among these scores, midterm clinical scores and magnetic resonance imaging (MRI) evaluations is unknown. The relationship between the second-look arthroscopic score at 1 year and the clinical scores or MRI at 3 years was evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effectiveness of 8-week vs. 12-week glecaprevir and pibrentasvir (GLE/PIB) treatment for chronic hepatitis C, focusing on both non-cirrhotic and cirrhotic patients in Japan.
  • The study enrolled 1,275 patients and primarily measured the sustained virological response (SVR) rates for different treatment durations and liver conditions.
  • Results showed high SVR rates (98.9% to 100%) across all groups, indicating that both 8-week and 12-week treatment regimens are effective regardless of liver fibrosis status.
View Article and Find Full Text PDF

Objective: We aimed to assess the prevalence of hazardous drinking and potential alcohol dependence among Japanese primary care patients, and their readiness to change and awareness of others' concerns.

Methods: From July to August 2023, we conducted a multi-site cross-sectional study as a screening survey for participants in a cluster randomized controlled trial. The trial included outpatients aged 20-74 from primary care clinics.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the safety of re-administering EGFR-tyrosine kinase inhibitors (TKIs) in patients who had experienced pneumonitis from osimertinib, particularly focusing on the risk of recurrent pneumonitis.
  • - Out of 124 patients treated, 54.8% underwent EGFR-TKI rechallenge, with a 27% recurrence rate of pneumonitis within 12 months, showing that patients on osimertinib had a significantly higher risk of recurrence compared to those on older EGFR-TKIs.
  • - Findings indicate that osimertinib leads to higher rates of recurrent pneumonitis upon rechallenge compared to traditional EGFR-TKIs, suggesting more caution is
View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated the combination of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in Japanese patients with advanced non-squamous non-small cell lung cancer, aiming to find a safer alternative to traditional treatments.
  • *The treatment resulted in a 56.5% overall response rate, with most patients experiencing tumor shrinkage or stable disease over a median follow-up of 42 months, leading to a median overall survival of 18.9 months.
  • *Although there were some manageable severe side effects such as neutropenia and anemia, no patient deaths were attributed to the treatment, indicating it is a well-tolerated option for this patient group.*
View Article and Find Full Text PDF